Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.86 USD | +9.83% | +1.67% | -45.15% |
Apr. 29 | Prime Medicine Shares Jump After Application for Chronic Granulomatous Disease Treatment Gets FDA Clearance | MT |
Apr. 29 | Prime Medicine Gets FDA Clearance for PM359 IND Application | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.15% | 560M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+2.62% | 22.18B | |
-16.67% | 21.2B | |
-8.96% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- PRME Stock
- News Prime Medicine, Inc.
- Prime Medicine 2023 Net Loss Narrows